Journal article

PND56 - A COST-EFFECTIVENESS ANALYSIS USING REAL-WORLD DATA FROM THE MSBASE REGISTRY: COMPARING NATALIZUMAB TO FINGOLIMOD IN PATIENTS WITH INADEQUATE RESPONSE TO DISEASE-MODIFYING THERAPIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN

W Herring, IG Gould, L Ruiz, T Dort, Y Zhang, C Acosta, R Hyde, T Spelman, H Butzkueven

Value in Health | Elsevier BV | Published : 2018

DOI: 10.1016/j.jval.2018.09.2022